Checker for Interactions Between Codeine and Cymbalta

No Prescription Needed

Interactions between Codeine and Cymbalta

This report displays potential drug interactions between codeine and Cymbalta (duloxetine).

Drug Interactions

DULoxetine may reduce the effectiveness of codeine. If you have been taking codeine and are starting treatment with DULoxetine, you may need a dose adjustment. It is important to inform your doctor if your condition changes or you experience reduced or inadequate relief of your symptoms. Additionally, tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Drug and Food Interactions

DULoxetine may cause liver damage, and taking it with alcohol may increase that risk. While being treated with DULoxetine, you should avoid or limit the use of alcohol. If you experience fever, chills, joint pain or swelling, excessive tiredness or weakness, unusual bleeding or bruising, skin rash or itching, loss of appetite, nausea, vomiting, dark colored urine, or yellowing of the skin or the whites of your eyes, call your doctor immediately as these may be symptoms of liver damage. It is important to inform your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Therapeutic Duplication Warnings

No warnings were found for your selected drugs. Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.

Report Options

Share by QR Code: QR code containing a link to this page.

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.

  • Major: Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
  • Moderate: Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
  • Minor: Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
  • Unknown: No interaction information available.
  • Further Information

    Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

    Medical Disclaimer

    Leave a Reply

    Your email address will not be published. Required fields are marked *